We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Sanofi
SNY
$107B
| $4.6M | 0.01% |
93,032
-74,064
| -44% | -$3.54M |
|
|
MON
527
DELISTED
Monsanto Co
MON
| $4.57M | 0.01% |
40,611
-3,053
| -7% | -$363K |
|
528
Edgewell Personal Care
EPC
$1.34B
| $4.48M | 0.01% |
43,811
-3,436
| -7% | -$340K |
|
|
PMC
529
DELISTED
PharMerica Corporation
PMC
| $4.44M | 0.01% |
+157,496
| New | +$3.91M |
|
|
MCF
530
DELISTED
Contango Oil & Gas Co.
MCF
| $4.34M | 0.01% |
197,333
-3,546
| -2% | -$91.2K |
|
|
ESND
531
DELISTED
Essendant Inc.
ESND
| $4.32M | 0.01% |
+105,372
| New | +$4.28M |
|
532
VeriSign
VRSN
$26.4B
| $4.26M | 0.01% |
63,655
-39,213
| -38% | -$2.38M |
|
|
TNAV
533
DELISTED
Telenav Inc.
TNAV
| $4.26M | 0.01% |
537,935
+205,950
| +62% | +$1.59M |
|
|
QVCGA
534
DELISTED
QVC Group Inc Series A
QVCGA
| $4.21M | 0.01% |
2,968
-224
| -7% | -$312K |
|
|
NTUS
535
DELISTED
Natus Medical Inc
NTUS
| $4.19M | 0.01% |
106,220
-38,570
| -27% | -$1.42M |
|
536
Travel + Leisure Co
TNL
$4.36B
| $4.18M | 0.01% |
102,346
-7,890
| -7% | -$314K |
|
537
General Motors
GM
$75.7B
| $4.12M | 0.01% |
109,900
-257,200
| -70% | -$9.35M |
|
538
Ubiquiti
UI
$36.3B
| $4.11M | 0.01% |
+139,012
| New | +$4.11M |
|
|
VCRA
539
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.08M | 0.01% |
411,706
+51,107
| +14% | +$505K |
|
|
REMY
540
DELISTED
REMY INTL INC NEW COMMON
REMY
| $4.07M | 0.01% |
+183,225
| New | +$3.98M |
|
541
Teradata
TDC
$2.68B
| $4.06M | 0.01% |
91,969
+15,871
| +21% | +$694K |
|
|
FMER
542
DELISTED
FIRSTMERIT CORP
FMER
| $4.03M | 0.01% |
211,502
-17,940
| -8% | -$325K |
|
|
RKT
543
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $4M | 0.01% |
62,100
+3,325
| +6% | +$218K |
|
|
CBI
544
DELISTED
Chicago Bridge & Iron Nv
CBI
| $3.98M | 0.01% |
80,766
-29,801
| -27% | -$1.25M |
|
545
Cooper-Standard Automotive
CPS
$473M
| $3.97M | 0.01% |
67,121
-5,261
| -7% | -$288K |
|
546
Centene
CNC
$32B
| $3.94M | 0.01% |
111,414
-41,986
| -27% | -$1.26M |
|
547
Micron Technology
MU
$1.05T
| $3.94M | 0.01% |
+145,100
| New | +$4.34M |
|
|
FFIC
548
DELISTED
Flushing Financial
FFIC
| $3.9M | 0.01% |
194,348
-15,521
| -7% | -$304K |
|
|
GNC
549
DELISTED
GNC Holdings, Inc.
GNC
| $3.88M | 0.01% |
79,055
-64,681
| -45% | -$2.98M |
|
|
SHOE
550
Shoe Station Group
SHOE
$372M
| $3.85M | 0.01% |
261,312
-264,480
| -50% | -$3.28M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.